Scientific Company Directory

Agilent (www.agilent.com) is a leader in life sciences, clinical research, diagnostics and applied chemical markets. With over 11,000 employees worldwide, the company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent's expertise and trusted collaboration give them the highest confidence in our solutions. Agilent focuses its expertise on six key markets, where we help our customers achieve their goals: • Food: Agilent products can help ensure that our global food supply is free of contaminants-whether chemical, viral, bacterial or microbiological • Environmental and Forensics: From pesticides to pharmaceutical residues to trace metals, Agilent provides fast, accurate and sensitive analytical methods for monitoring contaminants affecting quality of life • Pharmaceutical: Agilent has one of the broadest solutions portfolios of any company serving the pharmaceutical industry • Diagnostics: Agilent's reliable diagnostic products give doctors the information they need in the fight against cancer and other diseases • Chemical and Energy: The world runs on energy, and energy companies need to locate, extract and refine fuels efficiently and cost-effectively • Clinical Research: Most life sciences and clinical research is done at top-tier universities, with funding from governments around the world

Akoya Biosciences' history represents the rapid advancement driving the field of multiplexed biomarker analysis and immunofluorescence tissue analysis. Today's Akoya portfolio spans the spectrum from powerful tools for discovery of important biomarkers to clinical research applications. Akoya Biosciences was founded in 2015 to commercialize the CODEX System to enable ultra-high multiplexing for biomarker discovery. The fundamental CODEX technology was developed in the lab of Dr. Garry Nolan at Stanford University, who has served as a pioneer in technological and computational methods to enable a better understanding of tissue architecture and its contribution to disease pathology. The Phenoptics™ technology was originally conceived and developed by Cambridge Research & Instrumentation, co-founded by Peter Miller and Cliff Hoyt, acquired by Caliper in 2010, which was subsequently acquired by PerkinElmer in 2011. The Phenoptics™ technology was promptly adopted as the industry standard for multiplexed tissue analysis for translational and clinical research. The partnership between PerkinElmer and Telegraph Hill Partners, announced in November of 2018, created the current Akoya Biosciences. This combined portfolio of complementary technologies will continue to fuel groundbreaking advancements in cancer immunology, immunotherapy and a wide range of pathology research.

ACD shortens the path to personalized medicine by unlocking the power of RNA biomarkers. Advanced Cell Diagnostics, Inc. (ACD) is a leader in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. Based in the heart of Silicon Valley, ACD was founded and managed by experienced entrepreneurs in the life science industry. ACD's products and services are based on its proprietary RNAscope® Technology, the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity.

As an innovator in reagents and tools, our purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, we offer highly validated biological binders and assays to address important targets in critical biological pathways.

Automata was founded with a clear aim: to unlock human potential with automation. Through our collaboration with some of the world's leading pathology labs, we've developed the most comprehensive lab automation platform on the market. By simplifying environments and empowering people, Automata enables labs to scale with precision and creates new opportunities for scientists to accelerate innovation.

ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines, microorganisms, and associated data for academia, industry, and government. With a history of scientific contributions spanning nearly a century, ATCC offers an unmatched combination of being the world's largest and most diverse collection of biological reference materials and data, and is a mission-driven, trusted partner that supports and encourages scientific collaboration. ATCC products, services, partnerships, and people provide the global scientific community with credible, advanced, model systems to support complex research and innovations in basic science, drug discovery, translational medicine, and public health. ATCC is a 501(c)3 nonprofit organization with headquarters in Manassas, Virginia, and a research and technology center of excellence in Gaithersburg, Maryland. Visit atcc.org to learn more.

ABSA International (ABSA) was founded in 1984 to promote biosafety as a scientific discipline and serve the growing needs of biosafety professionals throughout the world. Its goals are to provide a professional association that represents the interests and needs of practitioners of biological safety, and to provide a forum for the continued and timely exchange of biosafety information.

A pioneer in microarray technology and a leader in genomics analysis, Affymetrix now develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at the cell, protein, and gene level, facilitating the rapid translation of results into biology for a better world.

Advanced Instruments, Inc., is headquartered in Norwood, Massachusetts. Founded in 1955, the company is the world's foremost authority for the application of Freezing Point Depression technology for measuring the osmolality of solutions. Since the company's inception laboratory professionals have looked to Advanced Instruments for exceptional customer support and leading edge tools for the diagnostic laboratory. Innovative solutions for common laboratory problems remain the mission of Advanced Instruments. Advanced Instruments proudly makes and markets laboratory products under the industry recognized brands of Fiske Associates, Spiral Biotech, and D & F Control Systems, and through its wholly owned subsidiaries Delta Instruments, and Mart Microbiology. Each of the Advanced Instruments companies is focused on designing and engineering the most state-of-the-art diagnostic systems for medical and industrial laboratories. All of our products are backed by a team of specialists with the experience to quickly implement and optimize our systems for your specific laboratory needs.

Atlas Antibodies is a Swedish biotechnology company driving leading research worldwide through providing affinity-purified monoclonal and polyclonal antibodies and control antigens. Our product portfolio extensively covers human proteins in cells, tissues, and organs. With our roots in the Human Protein Atlas project, an integration of antibody-based imaging, proteomics, and transcriptomics, our antibodies are selective and specific for their target proteins through our extensive validation process, ensuring reproducible results. We support you in your research. Our scientific support content and newsletter provide you with timely information about new product releases, research highlights, posters, infographics, and much more. In addition, our website contains informative whitepapers, protocols, guides, roundups of recent research papers, and blog posts.

Analytik Jena is a provider of instruments and products in the areas of analytical measuring technology and life science. Its portfolio includes the most modern analytical technology and complete systems for bioanalytical applications in the life science area. Comprehensive service offerings as well as device-specific consumables and disposables, such as reagents or plastic articles, complete the Group's extensive range of products.

AllSeq has created the world's first Sequencing Marketplace, which offers competitive bids on sequencing projects from our global network of service providers. Our online forms help guide you to create an accurate description of your sequencing project, ensuring that you receive accurate, consistent bids. Or you can browse our comprehensive list of service providers, filtering by platform, application and specialty. Our NGS Knowledge Bank, a neutral source of information on the various sequencing technologies, platforms and applications, can help guide your project design. Our NGS Conference list includes over 100 sequencing and genomics conferences annually.

Advion is the partner of choice for biopharmaceutical, academic/government researchers, and industrial chemists seeking to enhance their chemical synthesis knowledge, workflow and mass spectrometry results. Using our deep scientific and engineering expertise, we develop a broad portfolio of chemist-centric, purpose-built mass spectrometers, nanoelectrospray ionization sources, flow-chemistry synthesis systems and consumables characterized by their reliability, high quality and flexibility.

Alere delivers reliable and actionable information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally.

Advance Cell Diagnostics - a Bio-Techne brand, based in Silicon Valley, ACD's products and pharma assay services are based on its proprietary RNAscope™ technology, the first multiplex fluorescent and chromogenic in situ hybridization platform, capable of detecting and quantifying single molecules of RNA in situ. ACD has two product lines, namely RNAscope and BaseScope™ consisting of assay reagent kits and 15,000+ off-the-shelf probes in addition to a Pharma Assay Services business which allow customers to run assays for their unique targets rapidly. Since its first launch in 2011, the technology boasts 1200+ citations, a new publication each day now, for single, duplex and multiplex RNA analysis. ACD's products and services are based on its proprietary RNAscopeTechnology, the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity. In addition to its ongoing efforts to develop proprietary diagnostic tests for cancer management, ACD also establishes partnerships with pharmaceutical and biotechnology companies to validate biomarkers for targeted therapeutic development

The Association of Primate Veterinarians (APV) is an international organization consisting of over 400 veterinarians concerned with the health, care and welfare of nonhuman primates (NHPs). APV was informally initiated in 1973 by a key group of attendees at the Workshop in the Clinical Care of Nonhuman Primates, March 7-8, 1973 (National Institutes of Health, Bethesda, Maryland). The organization became more formally recognized, as the Association of Primate Veterinary Clinicians, when bylaws were established at the Annual Workshop in 1979. In 1983, the organization's name was changed to the Association of Primate Veterinarians. Our current membership consists of veterinarians who work with, provide and oversee care for a wide variety of NHP species in a broad range of settings. These settings include research facilities in major universities including the National Primate Research Centers, industry, and zoos as well as breeders and importers of primates for research. Our objectives are to promote the dissemination of information relating to the health, care and welfare of nonhuman primates; to provide a mechanism by which primate veterinarians may speak collectively on matters regarding nonhuman primates; and to promote fellowship among primate veterinarians.

Since 1987, Astrea Bioseparations has been pioneering the design, development and manufacture of affinity purification technology for lab-scale and industrial-scale bioprocessing. With over 25 years experience and success in the development of affinity products and design of new custom adsorbents, Astrea is a world leader in its field. Astrea Bioseparations has sales and support offices in North America and Europe, R&D facilities in Cambridge, UK and manufacturing facilities located on the Isle of Man, British Isles and Joliette, QC, Canada ensuring that we are able to meet your needs and support your application wherever you are.